• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.33% Nasdaq Up1.33%

    Neogenomics Inc. (NEO)

    8.04 Up 0.07(0.88%) Jun 30, 4:00PM EDT
    CompetitorsGet Competitors for:
    Direct Competitor Comparison 
    Market Cap:620.03MN/A2.15B13.34B228.23M
    Qtrly Rev Growth (yoy):1.59N/A0.060.300.16
    Revenue (ttm): 136.48M63.70M1757.30M9.03B50.01M
    Gross Margin (ttm):0.45N/A0.790.340.46
    EBITDA (ttm):12.62MN/A209.90M1.74B-2.64M
    Operating Margin (ttm): 0.01N/A0.240.15-0.16
    Net Income (ttm):-7.31M-4.50M1108.30M594.00MN/A
    EPS (ttm):-0.11N/A1.485.77N/A
    P/E (ttm):N/AN/A20.6822.6026.87
    PEG (5 yr expected):3.35N/A1.271.471.40
    P/S (ttm):4.50N/A2.841.473.08
    Pvt1 = Cellmark Forensics, Inc. (privately held)
    MYGN = Myriad Genetics, Inc.
    LH = Laboratory Corp. of America Holdings
    Industry = Medical Laboratories & Research
    1 = As of 2010  

    News on Direct Competitors 

    Currency in USD.